249 related articles for article (PubMed ID: 17855021)
1. Echinacea alkylamides modulate induced immune responses in T-cells.
Matthias A; Banbury L; Bone KM; Leach DN; Lehmann RP
Fitoterapia; 2008 Jan; 79(1):53-8. PubMed ID: 17855021
[TBL] [Abstract][Full Text] [Related]
2. Alkylamides from echinacea modulate induced immune responses in macrophages.
Matthias A; Banbury L; Stevenson LM; Bone KM; Leach DN; Lehmann RP
Immunol Invest; 2007; 36(2):117-30. PubMed ID: 17365014
[TBL] [Abstract][Full Text] [Related]
3. Effect of drying temperature on alkylamide and cichoric acid concentrations of Echinacea purpurea.
Stuart DL; Wills RB
J Agric Food Chem; 2003 Mar; 51(6):1608-10. PubMed ID: 12617592
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins.
Dalby-Brown L; Barsett H; Landbo AK; Meyer AS; Mølgaard P
J Agric Food Chem; 2005 Nov; 53(24):9413-23. PubMed ID: 16302756
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous analysis of alkamides and caffeic acid derivatives for the identification of Echinacea purpurea, Echinacea angustifolia, Echinacea pallida and Parthenium integrifolium roots.
Laasonen M; Wennberg T; Harmia-Pulkkinen T; Vuorela H
Planta Med; 2002 Jun; 68(6):572-4. PubMed ID: 12094312
[TBL] [Abstract][Full Text] [Related]
6. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
Sasagawa M; Cech NB; Gray DE; Elmer GW; Wenner CA
Int Immunopharmacol; 2006 Jul; 6(7):1214-21. PubMed ID: 16714226
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis.
Tsai YL; Chiu CC; Yi-Fu Chen J; Chan KC; Lin SD
J Ethnopharmacol; 2012 Oct; 143(3):914-9. PubMed ID: 22971663
[TBL] [Abstract][Full Text] [Related]
8. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
[TBL] [Abstract][Full Text] [Related]
9. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I).
Binns SE; Hudson J; Merali S; Arnason JT
Planta Med; 2002 Sep; 68(9):780-3. PubMed ID: 12357386
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations.
Matthias A; Addison RS; Agnew LL; Bone KM; Watson K; Lehmann RP
Phytomedicine; 2007 Sep; 14(9):587-90. PubMed ID: 17289362
[TBL] [Abstract][Full Text] [Related]
12. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
Gulledge TV; Collette NM; Mackey E; Johnstone SE; Moazami Y; Todd DA; Moeser AJ; Pierce JG; Cech NB; Laster SM
J Ethnopharmacol; 2018 Feb; 212():166-174. PubMed ID: 29042288
[TBL] [Abstract][Full Text] [Related]
13. Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations.
Livesey J; Awang DV; Arnason JT; Letchamo W; Barrett M; Pennyroyal G
Phytomedicine; 1999 Nov; 6(5):347-9. PubMed ID: 11962542
[TBL] [Abstract][Full Text] [Related]
14. Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide.
Spelman K; Iiams-Hauser K; Cech NB; Taylor EW; Smirnoff N; Wenner CA
Int Immunopharmacol; 2009 Oct; 9(11):1260-4. PubMed ID: 19712756
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes.
Matthias A; Gillam EM; Penman KG; Matovic NJ; Bone KM; De Voss JJ; Lehmann RP
Chem Biol Interact; 2005 Jun; 155(1-2):62-70. PubMed ID: 15885678
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea).
Morazzoni P; Cristoni A; Di Pierro F; Avanzini C; Ravarino D; Stornello S; Zucca M; Musso T
Fitoterapia; 2005 Jul; 76(5):401-11. PubMed ID: 15949903
[TBL] [Abstract][Full Text] [Related]
18. HPLC method validated for the simultaneous analysis of cichoric acid and alkamides in Echinacea purpurea plants and products.
Mølgaard P; Johnsen S; Christensen P; Cornett C
J Agric Food Chem; 2003 Nov; 51(24):6922-33. PubMed ID: 14611148
[TBL] [Abstract][Full Text] [Related]
19. Alkamides from Echinacea inhibit cyclooxygenase-2 activity in human neuroglioma cells.
Hinz B; Woelkart K; Bauer R
Biochem Biophys Res Commun; 2007 Aug; 360(2):441-6. PubMed ID: 17599805
[TBL] [Abstract][Full Text] [Related]
20. Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity.
Cech NB; Tutor K; Doty BA; Spelman K; Sasagawa M; Raner GM; Wenner CA
Planta Med; 2006 Dec; 72(15):1372-7. PubMed ID: 17054047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
